Quinn Opportunity Partners’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Sell
16,000
-22,082
-58% -$1.4M 0.06% 207
2025
Q4
$2.42M Sell
38,082
-235,579
-86% -$14.7M 0.11% 163
2025
Q3
$15M Buy
273,661
+78,722
+40% +$3.24M 1.1% 15
2025
Q2
$6.44M Buy
194,939
+65,000
+50% +$2.26M 0.55% 52
2025
Q1
$5.22M Buy
129,939
+14,000
+12% +$643K 0.37% 80
2024
Q4
$5.45M Buy
115,939
+9,302
+9% +$483K 0.4% 73
2024
Q3
$5.63M Buy
106,637
+16,000
+18% +$892K 0.56% 49
2024
Q2
$4.91M Buy
90,637
+44,260
+95% +$2.67M 0.57% 50
2024
Q1
$3.25M Buy
46,377
+38,377
+480% +$2.97M 0.38% 74
2023
Q4
$668K Buy
+8,000
New +$290K 0.08% 140

Other funds holding CYTK